您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA
专利权人:
PURYTRA FARMACEUTICI S.P.A.
发明人:
Guido PURICELLI,Salvatore CUZZOCREA,Elena SGARAVATTI,Daniele PIETRA
申请号:
US16064889
公开号:
US20200261528A1
申请日:
2016.12.21
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to a pharmaceutical composition comprising: —;an extract of Ajuga reptans comprising an amount of phenylpropanoids from 30% to 70% by weight with respect to the weight of the extract, wherein said amount of phenylpropanoids comprises an amount from 10 to 50% of teupolioside with respect to the total phenylpropanoid weight, and —;an extract of Epilobium comprising an amount from 20 to 50% by weight of polyphenols with respect to the weight of the extract, wherein said amount of polyphenols comprises up to 3% by weight of oenothein B with respect to the total amount of polyphenols. Also described is the pharmaceutical composition of the invention for use in the treatment of prostatic diseases, in particular the benign prostatic hyperplasia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充